DILIGENT PHARMA, INC. – Trademark Portfolio
Entity Type: 03
DILIGENT PHARMA, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 4 are pending. Notable registered marks include DP, DILIGENT, and DILIGENT PHARMA. The owner is based in PRINCETON, NJ.
179 NASSAU ST., SUITE 3A
PRINCETON, NJ 08542
Showing of trademarks Trademarks
Trademark Classifications
DILIGENT PHARMA, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does DILIGENT PHARMA, INC. have?
DILIGENT PHARMA, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending.
What trademark classes does DILIGENT PHARMA, INC. file in?
DILIGENT PHARMA, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are DILIGENT PHARMA, INC.'s most well-known trademarks?
DILIGENT PHARMA, INC.'s registered trademark portfolio includes well-known marks such as DP, DILIGENT, and DILIGENT PHARMA. These are among 3 currently registered trademarks in the portfolio.
What is DILIGENT PHARMA, INC.'s trademark registration success rate?
DILIGENT PHARMA, INC. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 4 applications are pending review.